154 related articles for article (PubMed ID: 37896180)
21. Subconjunctival Delivery of p75NTR Antagonists Reduces the Inflammatory, Vascular, and Neurodegenerative Pathologies of Diabetic Retinopathy.
Galan A; Barcelona PF; Nedev H; Sarunic MV; Jian Y; Saragovi HU
Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):2852-2862. PubMed ID: 28570737
[TBL] [Abstract][Full Text] [Related]
22. Protective effects of a novel drug RC28-E blocking both VEGF and FGF2 on early diabetic rat retina.
Yang QH; Zhang Y; Jiang J; Wu MM; Han Q; Bo QY; Yu GW; Ru YS; Liu X; Huang M; Wang L; Zhang XM; Fang JM; Li XR
Int J Ophthalmol; 2018; 11(6):935-944. PubMed ID: 29977804
[TBL] [Abstract][Full Text] [Related]
23. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
24. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
25. Retinal delivery of celecoxib is several-fold higher following subconjunctival administration compared to systemic administration.
Ayalasomayajula SP; Kompella UB
Pharm Res; 2004 Oct; 21(10):1797-804. PubMed ID: 15553225
[TBL] [Abstract][Full Text] [Related]
26. Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studies.
Lupo G; Motta C; Giurdanella G; Anfuso CD; Alberghina M; Drago F; Salomone S; Bucolo C
Biochem Pharmacol; 2013 Dec; 86(11):1603-13. PubMed ID: 24076420
[TBL] [Abstract][Full Text] [Related]
27. Assessment of a New Nanostructured Microemulsion System for Ocular Delivery of Sorafenib to Posterior Segment of the Eye.
Santonocito M; Zappulla C; Viola S; La Rosa LR; Solfato E; Abbate I; Tarallo V; Apicella I; Platania CBM; Maugeri G; D'Agata V; Bucolo C; De Falco S; Mazzone MG; Giuliano F
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922399
[TBL] [Abstract][Full Text] [Related]
28. Topically Administered NOX4 Inhibitor, GLX7013114, Is Efficacious in Treating the Early Pathological Events of Diabetic Retinopathy.
Dionysopoulou S; Wikstrom P; Bucolo C; Romano GL; Micale V; Svensson R; Spyridakos D; Mastrodimou N; Georgakis S; Verginis P; Walum E; Thermos K
Diabetes; 2023 May; 72(5):638-652. PubMed ID: 36821829
[TBL] [Abstract][Full Text] [Related]
29. Aflibercept ameliorates retinal pericyte loss and restores perfusion in streptozotocin-induced diabetic mice.
Seo EJ; Choi JA; Koh JY; Yoon YH
BMJ Open Diabetes Res Care; 2020 Oct; 8(1):. PubMed ID: 33077473
[TBL] [Abstract][Full Text] [Related]
30. Modulation of IL-1β and VEGF expression in rat diabetic retinopathy after PACAP administration.
D'Amico AG; Maugeri G; Rasà DM; Bucolo C; Saccone S; Federico C; Cavallaro S; D'Agata V
Peptides; 2017 Nov; 97():64-69. PubMed ID: 28964802
[TBL] [Abstract][Full Text] [Related]
31. Poly(lactic-co-glycolic acid) nanoparticle-mediated interleukin-12 delivery for the treatment of diabetic retinopathy.
Zeng L; Ma W; Shi L; Chen X; Wu R; Zhang Y; Chen H; Chen H
Int J Nanomedicine; 2019; 14():6357-6369. PubMed ID: 31496691
[TBL] [Abstract][Full Text] [Related]
32. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K
Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
[TBL] [Abstract][Full Text] [Related]
33. VEGF promotes diabetic retinopathy by upregulating the PKC/ET/NF-κB/ICAM-1 signaling pathway.
Zhang M; Zhou M; Cai X; Zhou Y; Jiang X; Luo Y; Hu Y; Qiu R; Wu Y; Zhang Y; Xiong Y
Eur J Histochem; 2022 Oct; 66(4):. PubMed ID: 36305269
[TBL] [Abstract][Full Text] [Related]
34. Resveratrol exhibits an effect on attenuating retina inflammatory condition and damage of diabetic retinopathy via PON1.
Chen Y; Meng J; Li H; Wei H; Bi F; Liu S; Tang K; Guo H; Liu W
Exp Eye Res; 2019 Apr; 181():356-366. PubMed ID: 30503749
[TBL] [Abstract][Full Text] [Related]
35. miR-142-5p regulates the progression of diabetic retinopathy by targeting IGF1.
Liu X; Li J; Li X
Int J Immunopathol Pharmacol; 2020; 34():2058738420909041. PubMed ID: 32116075
[TBL] [Abstract][Full Text] [Related]
36. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of scutellarin oral delivery efficacy by vitamin B12-modified amphiphilic chitosan derivatives to treat type II diabetes induced-retinopathy.
Wang J; Tan J; Luo J; Huang P; Zhou W; Chen L; Long L; Zhang LM; Zhu B; Yang L; Deng DY
J Nanobiotechnology; 2017 Mar; 15(1):18. PubMed ID: 28249594
[TBL] [Abstract][Full Text] [Related]
38. A non-invasive nanoparticle mediated delivery of triamcinolone acetonide ameliorates diabetic retinopathy in rats.
Mahaling B; Srinivasarao DA; Raghu G; Kasam RK; Bhanuprakash Reddy G; Katti DS
Nanoscale; 2018 Sep; 10(35):16485-16498. PubMed ID: 29897081
[TBL] [Abstract][Full Text] [Related]
39. Endomucin restores depleted endothelial glycocalyx in the retinas of streptozotocin-induced diabetic rats.
Niu T; Zhao M; Jiang Y; Xing X; Shi X; Cheng L; Jin H; Liu K
FASEB J; 2019 Dec; 33(12):13346-13357. PubMed ID: 31545913
[TBL] [Abstract][Full Text] [Related]
40. The ethanol extract of Zingiber zerumbet rhizomes mitigates vascular lesions in the diabetic retina.
Hong TY; Tzeng TF; Liou SS; Liu IM
Vascul Pharmacol; 2016 Jan; 76():18-27. PubMed ID: 26319672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
